Skip to main content
Log in

Epilepsy in children with leukodystrophies

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Background

Epilepsy might be one of the manifestations in children with leukodystrophies, but the incidence of epilepsy in different types of leukodystrophies is unclear yet.

Methods

A retrospective observational cohort study was performed on children diagnosed with leukodystrophies in Peking University First Hospital from January 2004 to June 2019, and the patients were followed for 5.5 years (0.4–14.2 years) after the first visit.

Results

A total of 333 patients were included. The overall incidence of epilepsy was 30.6% (102/333). Alexander disease had the highest incidence (77.3%, 51/66), followed by vanishing white matter disease (41.2%, 21/51), Canavan disease (33.3%, 1/3), megalencephalic leukoencephalopathy with subcortical cysts (32.1%, 9/28), X-linked adrenoleukodystrophy (23.1%, 3/13), Krabbe disease (18.8%, 3/16), metachromatic leukodystrophy (14.3%, 6/42), and Pelizaeus–Merzbacher disease (7.0%, 8/114). The incidence of epilepsy in leukodystrophies classified as astrocytopathies was higher than that in myelin disorders (55.9% vs. 11.2%, P < 0.001). Of the 102 patients with epilepsy, seizures were the chief complaint in 61.8% (63/102) and the initial symptom in 22.5% (23/102). The median age at seizure onset was 20.5 months (1 day–176 months). A total of 63.7% (65/102) of children were treated with antiepileptic drugs (AEDs), and the responder rate was 90.8% (59/65) at the last follow-up, including 71.2% (42/59) of children who were seizure free.

Conclusions

Epilepsy was not uncommon in children with leukodystrophies. Children with Alexander disease had the highest incidence; whereas, children with Pelizaeus–Merzbacher disease had the lowest incidence. Children with leukodystrophies classified as astrocytopathies were more prone to have epilepsy than those classified as myelin disorders. Most children with leukodystrophies who presented with epilepsy showed a good response to antiepileptic drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Parikh S, Bernard G, Leventer RJ et al (2015) A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies. Mol Genet Metab 114:501–515

    Article  CAS  Google Scholar 

  2. van der Knaap MS, Bugiani M (2017) Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms. Acta Neuropathol 134:351–382

    Article  Google Scholar 

  3. Bonkowsky JL, Nelson C, Kingston JL, Filloux FM, Mundorff MB, Srivastava R (2010) The burden of inherited leukodystrophies in children. Neurology 75:718–725

    Article  CAS  Google Scholar 

  4. Balslev T, Cortez MA, Blaser SI, Haslam RH (1997) Recurrent seizures in metachromatic leukodystrophy. Pediatr Neurol 17:150–154

    Article  CAS  Google Scholar 

  5. Karimzadeh P, Jafari N, Nejad Biglari H et al (2014) The Clinical features and diagnosis of Canavan's disease: a case series of Iranian patients. Iran J Child Neurol 8:66–71

    PubMed  PubMed Central  Google Scholar 

  6. Sakurai K, Ohashi T, Shimozawa N, Joo-Hyun S, Okuyama T, Ida H (2019) Characteristics of Japanese patients with X-linked adrenoleukodystrophy and concerns of their families from the 1st registry system. Brain Dev 41:50–56

    Article  Google Scholar 

  7. Velasco Parra HM, Maradei Anaya SJ, Acosta Guio JC, Arteaga Diaz CE, Prieto Rivera JC (2018) Clinical and mutational spectrum of Colombian patients with Pelizaeus Merzbacher Disease. Colomb Med 49:182–187

    PubMed  PubMed Central  Google Scholar 

  8. Golomb MR, Walsh LE, Carvalho KS, Christensen CK, DeMyer WE (2004) Clinical findings in Pelizaeus–Merzbacher disease. J Child Neurol 19:328–331

    Article  Google Scholar 

  9. Boison D, Steinhauser C (2018) Epilepsy and astrocyte energy metabolism. Glia 66:1235–1243

    Article  Google Scholar 

  10. Zafeiriou DI, Kontopoulos EE, Michelakakis HM, Anastasiou AL, Gombakis NP (1999) Neurophysiology and MRI in late-infantile metachromatic leukodystrophy. Pediatr Neurol 21:843–846

    Article  CAS  Google Scholar 

  11. Fukumizu M, Matsui K, Hanaoka S, Sakuragawa N, Kurokawa T (1992) Partial seizures in two cases of metachromatic leukodystrophy: electrophysiologic and neuroradiologic findings. J Child Neurol 7:381–386

    Article  CAS  Google Scholar 

  12. Lee JM, Kim AS, Lee SJ et al (2006) A case of infantile Alexander disease accompanied by infantile spasms diagnosed by DNA analysis. J Korean Med Sci 21:954–957

    Article  Google Scholar 

  13. Vembu P, Khaffaji S, Yadav G, Khan RA (2009) Juvenile metachromatic leukodystrophy in a boy with epilepsy. Neurosciences 14:290–291

    PubMed  Google Scholar 

  14. Hagberg B (1984) Krabbe's disease: clinical presentation of neurological variants. Neuropediatrics 15(Suppl):11–15

    Article  Google Scholar 

  15. Morse LE, Rosman NP (2006) Myoclonic seizures in Krabbe disease: a unique presentation in late-onset type. Pediatr Neurol 35:154–157

    Article  Google Scholar 

  16. Bonthius DJ, Karacay B (2016) Alexander disease: a novel mutation in GFAP leading to epilepsia partialis continua. J Child Neurol 31:869–872

    Article  Google Scholar 

  17. Arvidsson J, Hagberg B, Mansson JE, Svennerholm L (1995) Late onset globoid cell leukodystrophy (Krabbe's disease)—Swedish case with 15 years of follow-up. Acta Paediatr 84:218–221

    Article  CAS  Google Scholar 

  18. Wang PJ, Hwu WL, Shen YZ (2001) Epileptic seizures and electroencephalographic evolution in genetic leukodystrophies. J Clin Neurophysiol 18:25–32

    Article  CAS  Google Scholar 

  19. Kurlemann G, Palm DG (1991) Vigabatrin in metachromatic leucodystrophy; positive influence on spasticity. Dev Med Child Neurol 33:182

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by the National Science and Technology Major Project of the Ministry of Science and Technology of China (Grant no. 2017ZX09304029-006), National Natural Science Foundation of China (Grant no. 81741053), National Key Research and Development Program of China (Grant nos. 2016YFC0901505 and 2016YFC1306201), Beijing Key Laboratory of Molecular Diagnosis and Study on Pediatric Genetic Diseases (Grant no. BZ0317) and Research Seed Fund of Peking University First Hospital (Grant no. 2019SF14).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ye Wu.

Ethics declarations

Conflicts of interest

The authors declare no financial or other conflicts of interest.

Ethical standards

The study was approved by the clinical research ethics committee of the Peking University First Hospital. Written informed consents were obtained from the parents.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, J., Ban, T., Zhou, L. et al. Epilepsy in children with leukodystrophies. J Neurol 267, 2612–2618 (2020). https://doi.org/10.1007/s00415-020-09889-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-020-09889-y

Keywords

Navigation